$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Pharmaceutical compositions 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-009/50
출원번호 US-0021625 (1987-03-03)
발명자 / 주소
  • Cho Young W. (Chester NJ)
출원인 / 주소
  • Eurasiam Laboratories, Inc. (Chester NJ 02)
인용정보 피인용 횟수 : 192  인용 특허 : 11

초록

A composition adapted to administer a pharmocologically effective amount of a pharmaceutical agent when ingested orally comprising (a) a pharmaceutical agent; (b) a lipid coating materials; and (c) an enteric coating materials optionally comprising water soluble coating materials; emulsifying and so

대표청구항

A composition adapted for the oral administration of a selected proteinaceous material in biologically active form, said composition comprising: (a) particles having an average diameter of approximately 1 to about 100 microns and consisting essentially of a solid emulsifying agent and a surfactant;

이 특허에 인용된 특허 (11) 인용/피인용 타임라인 분석

  1. McArthur John N. (Toronto CA) Dawkins Peter D. (Taunton EN) Smith Mervyn J. H. (London EN), Anti-inflammatory dipeptide.
  2. Dreyfuss Michael M. (Basel CHX) Tscherter Hans (Allschwil CHX), Antibiotic S 31794/F-1.
  3. Kent John S. (Palo Alto CA), Cholesterol matrix delivery system for sustained release of macromolecules.
  4. Bilton Gerald L. (195 Scranton Ct. Zionsville IN 46077), Enzyme-containing digestive aid compostions.
  5. Kelly Lawrence A. (Morris Plains NJ), Liposome drug delivery systems.
  6. Ash Philip S. (Colchester GB2) Hider Robert C. (St. Osyth GB2), Liposomes and their use in treating human or other mammalian patients.
  7. Nagai Tsuneji (Chofu JPX) Machida Yoshiharu (Kawasaki JPX) Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX), Method and preparation for administration to the mucosa of the oral or nasal cavity.
  8. Davydov Anatoly B. (ulitsa Krasny Kazanets ; 19 ; korpus 1 ; kv. 283 Moscow SUX) Babaian Eduard A. (ulitsa Novatorov ; 40 ; korpus 2 ; kv. 50 Moscow SUX) Metelitsa Vladimir I. (Jubileiny prospekt ; 3, Pharmaceutical composition for the treatment of diabetes mellitus.
  9. Kidron Miriam (Jerusalem ILX) Ziv Ehud (Motza Ilit ILX) Bar-On Hanoch (Jerusalem ILX) Eldor Amiram (Jerusalem ILX), Pharmaceutical compositions containing insulin.
  10. Disteldorf Josef (Herne DEX) Hbel Werner (Herne DEX) Wolf Elmar (Herne DEX), Process for the trimerization of diisocyanates.
  11. Boettner Fred E. (Huntingdon Valley PA) Neubeck Clifford E. (Hatboro PA), Stabilization of internally administered pancreatic lipase.

이 특허를 인용한 특허 (192) 인용/피인용 타임라인 분석

  1. Bhagat, Hitesh R.; Goldberg, Jeffrey M.; Harianawala, Abizer I.; Brenner, Louis, Aliphatic amine polymer salts for tableting.
  2. Bhagat, Hitesh R.; Goldberg, Jeffrey M.; Harianawala, Abizer I.; Brenner, Louis, Aliphatic amine polymer salts for tableting.
  3. Bhagat, Hitesh R.; Goldberg, Jeffrey M.; Harianawala, Abizer I.; Brenner, Louis, Aliphatic amine polymer salts for tableting.
  4. Bhagat, Hitesh R.; Goldberg, Jeffrey M.; Harianawala, Abizer I.; Brenner, Louis, Aliphatic amine polymer salts for tableting.
  5. Dhal, Pradeep K.; Harris, David J.; Holmes-Farley, Stephen Randall; Huval, Chad C.; Nivorozhkin, Vitaly; Shutts, Bruce, Amide dendrimer compositions.
  6. Dhal, Pradeep K.; Harris, David J.; Holmes-Farley, Stephen Randall; Huval, Chad C.; Nivorozhkin, Vitaly; Shutts, Bruce, Amide dendrimer compositions.
  7. Dhal, Pradeep K.; Harris, David J.; Holmes-Farley, Stephen Randall; Huval, Chad C.; Nivorozhkin, Vitaly; Shutts, Bruce, Amide dendrimer compositions.
  8. Dhal, Pradeep K.; Holmes-Farley, Stephen Randall; Huval, Chad C., Amido-amine polymer compositions.
  9. Dhal, Pradeep K.; Holmes-Farley, Stephen Randall; Huval, Chad C., Amido-amine polymer compositions.
  10. Zyck, Daniel J.; Greenberg, Michael J.; Barkalow, David G.; Marske, Scott W.; Urnezis, Philip W.; Mazzone, Philip, Antacid chewing gum products coated with high viscosity materials.
  11. Adamo, Benoit; Polidoro, John M.; Overfield, Dennis; Sahi, Carl R.; Laurenzi, Brendan; Smutney, Chad C.; Kinsey, P. Spencer, Apparatus and method for simulating inhalation efforts.
  12. Keenan David,IEX ; Somers Padraig,IEX, Apparatus for producing a pharmaceutical product.
  13. Adamo, Benoit; McLean, Scott; Smutney, Chad C.; Polidoro, John M.; Sahi, Carl R., Apparatus, system and method for measuring resistance of an inhaler.
  14. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  15. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  16. Plijter Johannes Josef,NLX ; Meesters Gabriel Marinus Henricus,NLX, Bread improving composition.
  17. Bacaner, Marvin B.; Kreevoy, Maurice M., Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions.
  18. Marvin B. Bacaner ; Maurice M. Kreevoy, Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions.
  19. Henry T. Tyrpin ; Michael P. Russell ; David L. Witkewitz ; Sonya S. Johnson ; Ronald L. Ream ; Christine L. Corriveau, Caffeine coated chewing gum product and process of making.
  20. Stevenson, John J.; Moye-Sherman, Destardi, Catalysis of diketopiperazine synthesis.
  21. Stevenson, John J.; Moye-Sherman, Destardi, Catalysis of diketopiperazine synthesis.
  22. Barreca, Jack, Chewing gum.
  23. Barreca, Jack, Chewing gum with B vitamins.
  24. Barreca, Jack; Kovarik, Joseph E., Chewing gum with tomatidine.
  25. Johnson,Sonya S.; Barkalow,David G.; Greenberg,Michael J.; Sheldon,Gloria T., Coated chewing gum product and method of making.
  26. Zyck, Daniel J.; Greenberg, Michael J.; Barkalow, David G.; Marske, Scott W.; Schnell, Philip G.; Mazzone, Philip; Witkewitz, David L., Coated chewing gum products containing an acid blocker and process of preparing.
  27. Zyck, Daniel J.; Greenberg, Michael J.; Barkalow, David G.; Marske, Scott W.; Schnell, Philip G.; Mazzone, Philip; Hammond, John E.; Witkewitz, David L.; Sitler, Daniel J.; Petrocelli, Raynold M., Coated chewing gum products containing an antigas agent.
  28. Zyck, Daniel J.; Greenberg, Michael J.; Barkalow, David G.; Marske, Scott W.; Schnell, Philip G.; Mazzone, Philip, Coated chewing gum products containing antacid and method of making.
  29. Betageri, Guru V., Coated drug delivery formulations.
  30. Betageri, Guru V., Coated drug delivery formulations.
  31. Skiendzielewski, Stephen; Rose, Martin; Do, Ngoc, Colonic purgative composition with soluble binding agent.
  32. Lemko, Mark; Patel, Pravin M., Composition and method for the treatment of anorectal disorders.
  33. Fjellestad-Paulsen Anne,FRX, Composition for oral administration of peptides.
  34. Kimura Ken (31-3 Shimouma 1-chome Setagaya-ku ; Tokyo 154 JPX) Taniguchi Yushi (Oyama JPX) Satoh Kiichi (Oyama JPX) Saifuku Kouji (Shimodate JPX) Kihira Ken (Kawachi JPX) Ido Kenichi (Utsunomiya JPX), Composition for the treatment of helicobacter pylori infection.
  35. Waldman, Scott A.; Park, Jason; Schulz, Stephanie, Compositions and methods for identifying and targeting cancer cells of alimentary canal origin.
  36. Waldman, Scott A.; Park, Jason; Schulz, Stephanie, Compositions and methods for identifying and targeting cancer cells of alimentary canal origin.
  37. Waldman, Scott A.; Park, Jason; Schulz, Stephanie, Compositions and methods for identifying and targeting cancer cells of alimentary canal origin.
  38. Waldman, Scott A.; Park, Jason; Schulz, Stephanie, Compositions and methods for identifying and targeting cancer cells of alimentary canal origin.
  39. Bromley, Philip J., Compositions containing non-polar compounds.
  40. Bromley, Philip J., Compositions containing non-polar compounds.
  41. Bromley, Philip J., Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch.
  42. Waldman Scott A., Compositions that specifically bind to colorectal cancer cells and methods of using the same.
  43. Waldman Scott A. ; Pearlman Joshua M. ; Barber Michael T. ; Schulz Stephanie ; Parkinson Scott J., Compositions that specifically bind to colorectal cancer cells and methods of using the same.
  44. Waldman,Scott A.; Pearlman,Joshua M.; Barber,Michael T.; Schulz,Stephanie; Parkinson,Scott J., Compositions that specifically bind to colorectal cancer cells and methods of using the same.
  45. Waldman,Scott A.; Pearlman,Joshua M.; Barber,Michael T.; Schulz,Stephanie; Parkinson,Scott J., Compositions that specifically bind to colorectal cancer cells and methods of using the same.
  46. Hsu, Ann; Kou, Jim; Alani, Laman, Controlled release formulations of levodopa and uses thereof.
  47. Cheng, Xiu Xiu; Jan, Steve; Chou, Joseph; Chen, Chih-Ming, Controlled release metformin formulations.
  48. Xiu Xiu Cheng ; Chih-Ming Chen ; Steve Jan ; Joseph Chou, Controlled release oral tablet having a unitary core.
  49. Richardson, Peter; Baughman, Robert A.; Leone-Bay, Andrea; Costello, Donald, Delivery of active agents.
  50. Grant, Marshall L.; Stowell, Grayson W.; Menkin, Paul, Diketopiperazine microparticles with defined specific surface areas.
  51. Grant, Marshall L.; Stowell, Grayson W.; Menkin, Paul, Diketopiperazine microparticles with defined specific surface areas.
  52. Leone-Bay, Andrea; Moye-Sherman, Destardi; Wilson, Bryan R., Diketopiperazine salts for drug delivery and related methods.
  53. Leone-Bay, Andrea; Moye-Sherman, Destardi; Wilson, Bryan R., Diketopiperazine salts for drug delivery and related methods.
  54. Tyler, Joseph; Petersen, John S., Direct compression polymer tablet core.
  55. Tyler, Joseph; Petersen, John S., Direct compression polymer tablet core.
  56. Tyler, Joseph; Petersen, John S., Direct compression polymer tablet core.
  57. Smutney, Chad C.; Adamo, Benoit; Laurenzi, Brendan F.; Kinsey, P. Spencer, Dry powder drug delivery system and methods.
  58. Smutney, Chad C.; Adamo, Benoit; Polidoro, John M.; Kinsey, P. Spencer; Overfield, Dennis; Sahi, Carl; Billings, Christine; Marino, Mark T., Dry powder drug delivery system and methods.
  59. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
  60. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Bryant, Anthony; He, Tom; Mann, Alfred, Dry powder inhaler and system for drug delivery.
  61. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
  62. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfield, Dennis; Kraft, Kelly S.; Somerville, Karla, Dry powder inhaler and system for drug delivery.
  63. Smutney, Chad C.; Kinsey, P. Spencer; Sahi, Carl R.; Adamo, Benoit; Polidoro, John M.; McLean, Scott; Overfiled, Dennis; Bryant, Anthony, Dry powder inhaler and system for drug delivery.
  64. Bettman Marie Jean (Dayton OH) Percel Phillip J. (Troy OH) Powell Thomas C. (W. Alexandria OH), Effervescent microcapsules.
  65. Sunohara, Hideki; Kamaguchi, Ryosei; Kozaki, Toshio; Yoshikado, Masatomo; Higuchi, Junko, Encapsulated unsaturated fatty acid substance and method for producing the same.
  66. Qian, Yu; Zhang, Li Juan; Wu, Zhi Min; Zhou, Li Ying; Jiang, Wei; Ling, Li; Luo, Qian; Guo, Xin Dong, Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery.
  67. Betageri, Guru V., Enteric-coated proliposomal formulations for poorly water soluble drugs.
  68. Bromley, Philip J., Formulations of water-soluble derivatives of vitamin E and compositions containing same.
  69. Hamade Ryoji,JPX ; Yamamori Naoki,JPX ; Okahata Yoshio,JPX, Glucoxide derivatives for enzyme modification, lipid-coated enzymes, method of producing such enzymes and antifouling pa.
  70. Fabio, Karine; Guarneri, Joseph J.; Curley, Kieran; Grant, Marshall L.; Leone-Bay, Andrea, Heat-stable dry powder pharmaceutical compositions and methods.
  71. Grant, Marshall; Menkin, Paul; Stowell, Grayson W., High capacity diketopiperazine microparticles and methods.
  72. Grant, Marshall; Menkin, Paul; Stowell, Grayson W., High capacity diketopiperazine microparticles and methods.
  73. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  74. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  75. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  76. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  77. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  78. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  79. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  80. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
  81. Hokenson, Mark; Oberg, Keith A., Increasing drug affinity for crystalline microparticle surfaces.
  82. Smutney, Chad C.; Leone-Bay, Andrea; Galarza, Jose M.; Munoz, Hector; Martin, George R.; Grant, Marshall L., Inhalable vaccine compositions and methods.
  83. Poole, Trent; Steiner, Solomon S., Inhalation apparatus.
  84. Ekwuribe,Nnochiri N.; Price,Christopher H.; Still,James Gordon; Filbey,Jennifer Ann; Ansari,Aslam M.; Odenbaugh,Amy L.; Radhakrishnan,Balasingam, Insulin conjugates for treating diabetes mellitus.
  85. Naver, Helle; Schlein, Morten; Steensgaard, Dorte Bjerre; Petterson, Ingrid Vivika, Insulin formulations.
  86. Plate Nikolai Alfredovich (Moscow RUX) Valuev Lev Ivanovich (Moscow RUX) Valueva Tatyana Alexandrovna (Moscow RUX) Staroseltseva Ljudmila Konstantinovna (Moscow RUX) Ametov Alexandr Sergeevich (Mosco, Insulin-containing polymer composition for oral administration.
  87. Overfield, Dennis; Sahi, Carl R.; Adamo, Benoit; Kinsey, P. Spencer; McLean, Scott; Polidoro, John M.; Smutney, Chad C., Interactive apparatus and method for real-time profiling of inhalation efforts.
  88. Carlsson Lena Mariana Susann,SEX ; Clark Ross Graham ; Wong Wai Lee Tan, Ligand-mediated immunofunctional hormone binding protein assay method.
  89. Gallaher Daniel D. (Roseville MN) Hassel Craig A. (Coon Rapids MN), Lowering blood cholesterol levels using water soluble cellulose ethers.
  90. Leone-Bay, Andrea; Stowell, Grayson W.; Guarneri, Joseph J.; Carlson, Dawn M.; Grant, Marshall; Smutney, Chad C., Method and composition for treating migraines.
  91. Modi, Pankaj, Method for administering insulin to the buccal region.
  92. Modi,Pankaj, Method for administering insulin to the buccal region.
  93. Tijssen, Peter; Szelei, Jozsef; Zadori, Zoltan, Method for detecting infectious parvovirus in pharmaceutical preparations.
  94. Latino, Massimo; Ghidorsi, Luigi; Ortenzi, Giovanni, Method for dissolution testing of solid compositions containing digestive enzymes.
  95. Bodmeier Roland,DEX ; McGinity James W., Method for improving the dispersion of redispersible polymer powders.
  96. Wilson, Bryan R.; Grant, Marshall, Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
  97. Wilson, Bryan R.; Grant, Marshall, Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent.
  98. Benet Leslie Z. ; Wu Chi Yuan, Method for increasing bioavailability of oral pharmaceutical compositions.
  99. Benet Leslie ; Wu Chi Yuan, Method for increasing bioavailability of orally administered pharmaceutical compounds.
  100. Zyck, Daniel J.; Sitler, Daniel J.; Barkalow, David G.; Knutsen, Jonathan J.; Shen, Chungsea A.; Zuehlke, Julius W.; Schnell, Philip G., Method for making coated chewing gum products including a high-intensity sweetener.
  101. Witkewitz,David L.; Barkalow,David G.; Knutsen,Jonathan J.; Shen,Chungsea A.; Zuehlke,Julius W.; Yatka,Robert J., Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener.
  102. Huval, Chad C.; Holmes-Farley, Stephen Randall; Dhal, Pradeep K., Method for removing phosphate and polymer used therefore.
  103. Hokenson, Mark; Oberg, Keith A., Method of drug formulation.
  104. Hokenson, Mark; Oberg, Keith A., Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces.
  105. Hokenson, Mark; Oberg, Keith A., Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces.
  106. Oberg, Keith A.; Sulner, Joseph; Grant, Marshall L., Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents.
  107. Oberg, Keith A.; Sulner, Joseph; Grant, Marshall L., Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents.
  108. Zyck, Daniel J.; Greenberg, Michael J.; Barkalow, David G.; Marske, Scott W.; Schnell, Philip G.; Mazzone, Philip, Method of making coated chewing gum products containing various antacids.
  109. Johnson, Sonya S.; Record, David W.; Greenberg, Michael J.; Reed, Michael A.; Gudas, Victor V.; Schnell, Philip G.; Seielstad, Donald A.; Tyrpin, Henry T.; Russell, Michael P.; Witkewitz, David L.; S, Method of producing active agent coated chewing gum products.
  110. Richardson, Peter; Baughman, Robert A.; Potocka, Elizabeth; Boss, Anders Hasager; Petrucci, Richard, Method of treating diabetes type 2 by administering ultrarapid acting insulin.
  111. MacGregor, Alexander, Method of treating dysglycemia and glucose excursions.
  112. Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Methods and compositions for delivering peptides.
  113. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  114. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  115. Leone-Bay, Andrea; Houghten, Richard A.; Guarneri, Joseph J.; Stowell, Grayson W., Methods and compositions for treating pain.
  116. Ortenzi, Giovanni; Ghidorsi, Luigi, Methods for removing viral contaminants from pancreatic extracts.
  117. Weiner, David B.; Wang, Bin; Ugen, Kenneth, Methods of inducing mucosal immunity.
  118. Grabstein, Kenneth H.; Wang, Aijun; Nairn, Natalie Winblade; Graddis, Thomas James, Methods of modifying polypeptides comprising non-natural amino acids.
  119. Waldman, Scott A.; Park, Jason; Schulz, Stephanie, Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression.
  120. Cho Young W., Microparticular pharmaceutical compositions.
  121. Maio, Mario, Microspheres of pancreatic enzymes with high stability and production method thereof.
  122. Maio, Mario, Microspheres of pancreatic enzymes with high stability and production method thereof.
  123. Grabstein, Kenneth H.; Wang, Aijun; Nairn, Natalie Winblade; Graddis, Thomas James; McCraith, Stephen; Datta, Deepshikha, Modified human interferon-beta polypeptides.
  124. Grabstein, Kenneth H.; Wang, Andrea; Nairn, Natalie Winblade; McCraith, Stephen; Datta, Deepshikha, Modified human interferon-β polypeptides.
  125. Hsu, Ann; Dong, Liang C.; Ding, Amy; Gupta, Suneel, Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof.
  126. McGrew, Gordon N.; Barkalow, David G.; Johnson, Sonya S.; Record, David W.; Patel, Mansukh M.; Nimz, Jack D.; Zibell, Steven E.; Yatka, Robert J.; Greenberg, Michael J.; Aumann, Rebecca A.; Zyck, Dan, Nutraceuticals or nutritional supplements and method of making.
  127. Chen Chih-Ming ; Cheng Xiu Xiu ; Chou Joseph ; Jan Steve, Oral dosage form for the controlled release of a biguanide and sulfonylurea.
  128. Nomura Hideaki (Takasaki JPX) Maruyama Kazutoshi (Maebashi JPX), Oral dosage form of biologically active proteins.
  129. Arbit,Ehud; Abbas,Richat; Goldberg,Michael; Woods,T. Cooper; Dinh,Steven; Wong,Vivien, Oral insulin therapy.
  130. Ream, Ronald L.; Greenberg, Michael J.; Wokas, William J.; Corriveau, Christine L., Over-coated chewing gum formulations.
  131. Ream, Ronald L.; Greenberg, Michael J.; Wokas, William J.; Corriveau, Christine L., Over-coated chewing gum formulations.
  132. Ronald L. Ream ; Michael J. Greenberg ; William J. Wokas ; Christine L. Corriveau, Over-coated chewing gum formulations.
  133. Ronald L. Ream ; Michael J. Greenberg ; William J. Wokas ; Christine L. Corriveau, Over-coated chewing gum formulations.
  134. Ream Ronald L. ; Corriveau Christine L. ; Graff Gwendolyn ; Matulewicz Leonard, Over-coated chewing gum formulations including tableted center.
  135. Ream Ronald L. ; Corriveau Christine L. ; Graff Gwendolyn ; Matulewicz Leonard, Over-coated chewing gum formulations including tableted center.
  136. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  137. Stern, William; Consalvo, Angelo P., Peptide pharmaceutical for oral delivery.
  138. Stern, William; Consalvo, Angelo P., Peptide pharmaceutical for oral delivery.
  139. Stern, William; Consalvo, Angelo P., Peptide pharmaceutical for oral delivery.
  140. Stern, William; Consalvo, Angelo P., Peptide pharmaceutical for oral delivery.
  141. Stern, William; Consalvo, Angelo P., Peptide pharmaceutical for oral delivery.
  142. Barnwell Stephen George,GBX, Pharmaceutical composition containing a low detergent effect bile salt and an active compound that undergoes biliary ex.
  143. Shen, Robert W.; Walter, Gerald A., Pharmaceutical composition having two coating layers.
  144. Bob E. Sherwood ; John H. Staniforth GB; Edward A. Hunter, Pharmaceutical excipient having improved compressibility.
  145. John N. Staniforth GB; Bob E. Sherwood ; Edward A. Hunter, Pharmaceutical excipient having improved compressibility.
  146. Sherwood Bob E. ; Staniforth John H.,GBX ; Hunter Edward A., Pharmaceutical excipient having improved compressibility.
  147. Sherwood, Bob E.; Staniforth, John H.; Hunter, Edward A., Pharmaceutical excipient having improved compressibility.
  148. Staniforth John N.,GB2 ; Sherwood Bob E. ; Hunter Edward A., Pharmaceutical excipient having improved compressibility.
  149. Staniforth, John N.; Hunter, Edward A.; Sherwood, Bob E., Pharmaceutical excipient having improved compressibility.
  150. Staniforth, John N.; Sherwood, Bob E.; Hunter, Edward A., Pharmaceutical excipient having improved compressibility.
  151. Staniforth John N.,GBX ; Sherwood Bob E. ; Hunter Edward A., Pharmaceutical formulations having improved disintegration and/or absorptivity.
  152. Boss, Anders Hasager; Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Potentiation of glucose elimination.
  153. Boss, Anders Hasager; Steiner, Solomon S.; Woods, Rodney J.; Sulner, Joseph W., Potentiation of glucose elimination.
  154. Bromley, Philip J., Pre-spray emulsions and powders containing non-polar compounds.
  155. Cho, Young W.; Lee, Kwang-Ho, Pro-micelle pharmaceutical compositions.
  156. Song, Joo H.; Townsend, Donald J.; Record, David W.; Tyrpin, Henry T.; Russell, Michael P.; Schnell, Philip G.; Ream, Ronald L.; Corriveau, Christine L., Process for controlling release of active agents from a chewing gum coating and product thereof.
  157. John N. Staniforth GB; Bob E. Sherwood ; Edward A. Hunter ; Clifford M. Davidson, Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose.
  158. Staniforth, John N.; Sherwood, Bob E.; Hunter, Edward A.; Davidson, Clifford M., Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose.
  159. Kerkhof, Nicholas J., Process for producing nanoparticles by spray drying.
  160. Betageri, Guru V., Proliposomal drug delivery system.
  161. Madsen, Peter; Kjeldsen, Thomas B.; Hoeg-Jensen, Thomas; Jakobsen, Palle; Tagmose, Tina Moeller; Kodra, Janos Tibor, Protease stabilized acylated insulin analogues.
  162. Madsen, Peter; Kjeldsen, Thomas Boerglum; Hoeg-Jensen, Thomas; Jakobsen, Palle; Tagmose, Tina Moeller; Glendorf, Tine; Kodra, Janos Tibor; Garibay, Patrick William; Petersen, Jacob Sten, Protease stabilized acylated insulin analogues.
  163. Plate Nikolai A.,RUX ; Valuev Lev I.,RUX ; Valueva Tatyana A.,RUX ; Staroseltseva Ludmila K.,RUX ; Ametov Alexander S.,RUX ; Knyazhev Vladimir A.,RUX ; Henis Jay M.S., Protein-containing polymer composition for oral administration.
  164. Ishimaru Sueaki (Menuma JPX) Ouchi Kiyohisa (Menuma JPX) Takeuchi Kimito (Menuma JPX) Yamada Masaki (Menuma JPX), Readily absorbable drug formulation of NB-818.
  165. Waldman, Scott A., ST receptor binding compounds and methods of using the same.
  166. Bhagat, Hitesh R.; Goldberg, Jeffrey M., Sachet formulation for amine polymers.
  167. Benet Leslie (Belvedere CA) Wu Chi Y. (San Francisco CA), Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of.
  168. Gmunder, Charlean B.; Li, Weisheng; Ream, Ronald L, Sildenafil citrate chewing gum formulations and methods of using the same.
  169. Gmunder, Charlean B.; Li, Weisheng; Ream, Ronald L., Sildenafil citrate chewing gum formulations and methods of using the same.
  170. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  171. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  172. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions.
  173. Vrettos, John; Daggs, Thomas; Shields, Paul; Claudio, Raymundo, Solid oral dosage forms.
  174. Ortenzi, Giovanni; Marconi, Marco; Mapelli, Luigi, Stable digestive enzyme compositions.
  175. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  176. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  177. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  178. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  179. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  180. Kraft, Kelly Sullivan, Substituted diketopiperazine analogs for use as drug delivery agents.
  181. Hertelendy,Zsolt Istvan; Weiner,Murray; Howell,Michael; Thomas,Joseph, Urogenital or anorectal transmucosal vaccine delivery system.
  182. Waldman, Scott A.; Pitari, Giovanni Mario; Park, Jason; Schulz, Stephanie; Wolfe, Henry R.; Lubbe, Wilhelm, Use of GCC ligands.
  183. Huang, Yu Liang; Chen, Xu Wen, Use of IL-22 for the treatment of conditions of metabolic disorders.
  184. Huang, Yu Liang; Chen, Xu Wen, Use of IL-22 for the treatment of conditions of metabolic disorders.
  185. Huang, Yu Liang; Chen, Xu Wen, Use of IL-22 for the treatment of conditions of metabolic disorders.
  186. Benet Leslie Z. ; Wacher Vincent J. ; Benet Reed M., Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds.
  187. Benet Leslie Z. ; Wacher Vincent J. ; Benet Reed M., Use of essential oils to increase bioavailability of oral pharmaceutical compounds.
  188. Benet Leslie Z. ; Wacher Vincent J. ; Benet Reed M., Use of essential oils to increase bioavailability of orally administered pharmaceutical compounds.
  189. Richardson, Peter; Baughman, Robert A.; Potocka, Elizabeth; Boss, Anders Hasager; Petrucci, Richard, Use of ultrarapid acting insulin.
  190. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  191. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.
  192. Marathi, Upendra K.; Childress, Susann Edler; Gammill, Shaun L.; Strozier, Robert W., pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로